Indefinite Delivery Contract 75D30120D07985

Award Date 4/23/20
Last Date to Order 4/22/21
Federal Agency
CDC Pittsburgh
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Service Contract Inventory
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Corgenix Medical Corporation, a foreign-owned, small disadvantaged business manufacturer of goods. The $23,650,000 contract is for "SURGE SEROLOGY TESTING" services, with a period of performance from April 23, 2020 to April 22, 2021. As an IDC, this contract allows the CDC to issue task orders for serology testing services as needed. The contract does not appear to have any...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), a civilian agency, to Battelle Memorial Institute, a non-profit organization and manufacturer of goods, to provide serology surge testing services. The contract has a ceiling value of $23,750,000 and a period of performance from April 2020 to April 2021. As a multiple award IDC, this vehicle provides the CDC with flexible access to Battelle's scientific and technical capabilities in areas...
The Centers for Disease Control and Prevention awarded an indefinite delivery contract to Laboratory Corporation of America Holdings to provide surge serology testing services in support of COVID-19 response efforts. The multiple award contract has a potential value of $23.75 million and was awarded on May 7, 2020 to aid the agency through April 22, 2021. Two firm fixed price delivery orders have been issued against the contract to date. Laboratory Corporation will perform testing from its...
This Indefinite Delivery Contract is a multiple award IDIQ awarded by the Centers for Disease Control and Prevention (CDC) to Ginkgo Bioworks, Inc., a biotechnology company based in Boston, Massachusetts. The $118 million contract, with an ultimate completion date of September 5, 2029, is for "Test Surge and Data Sharing" services. Under this IDIQ, Ginkgo Bioworks is expected to provide testing and data sharing capabilities to support the CDC's public health monitoring and emergency...
This federal contract IDV award is a multiple award Indefinite Delivery, Indefinite Quantity (IDIQ) contract titled "TEST SURGE AND DATA SHARING MULTIPLE AWARD IDIQ" with a total ceiling value of $118,000,000.00. It was awarded by the Centers for Disease Control and Prevention (CDC) to the prime contractor, Arup Laboratories Inc., doing business as Associated Regional And University Pathologists, a not-for-profit clinical and anatomic pathology reference laboratory. The contract aims...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded an Indefinite Delivery Indefinite Quantity (IDIQ) contract, titled "Safety and Healthcare Epidemiology Prevention Research Development 2016" (SHEPheRD 2016), to the University of Washington (UW). The multiple-award IDIQ has a potential value of $200,000,000 and a period of performance from September 2016 to September 2021. Under this IDIQ, the CDC awarded a $599,925 firm fixed price...
The Centers for Disease Control and Prevention awarded a multiple award indefinite delivery contract to Quest Diagnostics Incorporated for surge serology testing services. The contract established a potential value of $23.75 million for Quest Diagnostics to provide COVID-19 antibody testing from its Secaucus, New Jersey laboratory in support of the CDC's pandemic response. A $14 million firm fixed price delivery order to Quest Diagnostics expanded the scope of work. Under the delivery order,...
The Indefinite Delivery Contract is a multiple award IDV issued by the Department of Health and Human Services Centers for Disease Control and Prevention. The contract supports the Safe Healthcare, Epidemiology, and Prevention Research Development Program under the SHEPHERD IDIQ 2021-2026 contract for Domains 1 and 3. With a potential value of $99 million and a period of performance through September 2026, the IDV aims to procure research and services to advance epidemiology and prevention of...
This indefinite delivery contract was awarded by the Centers for Disease Control and Prevention (CDC) to Ami Expeditionary Healthcare, LLC, a for-profit limited liability company. The single-award IDV has a ceiling value of $25,001,500 and is for the provision of commercial COVID-19 emergency response teams to support the CDC's pandemic response efforts. Under the IDV, the CDC has issued multiple time-and-materials and firm-fixed-price delivery orders to Ami Expeditionary Healthcare for services...
The University of Washington School of Medicine has been awarded a single-award Indefinite Delivery Contract (IDC) from the Department of Veterans Affairs (VA) to provide specialized laboratory testing services for the VA's Portland Medical Center. The contract has a period of performance through March 31, 2030 and a ceiling value of $335,000. Additionally, the University of Washington School of Medicine has been awarded a multiple-award Indefinite Delivery Vehicle (IDV) from the Centers for...

The Indefinite Delivery Contract is a multiple award issued by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh. It has a potential value of $23,750,000 and was awarded on April 23, 2020 to the University of Washington School of Medicine for SURGE SEROLOGY TESTING. No set-aside was used. Orders may be placed through April 22, 2021.

The purpose of the contract is to provide surge serology testing in support of the Centers for Disease Control and Prevention's efforts to monitor the prevalence and spread of SARS-CoV-2, the virus that causes COVID-19. The University of Washington School of Medicine will leverage its expertise in laboratory medicine and serology testing to deliver testing services that aim to aid the CDC's understanding of the scope and epidemiology of the COVID-19 pandemic. The parent company of the prime contractor, the University of Washington, will support these efforts through its resources and research capabilities.

The indefinite delivery contract mechanism and multiple awards indicate task orders will be issued on an as-needed basis to meet surge testing requirements, with the period of performance extending through April 2021 unless that date is modified. The $23.75 million potential value suggests a substantial testing capacity will be made available under this contract to respond to changing needs for serological data as the COVID-19 situation evolves.

Generated 1/4/24, 9:44 PM